Shanghai-based Univ Biotechnology supplies more than 4 million antibody-based life science reagents, instruments and lab services.
Based in Shanghai, China and established in 2004, Univ Biotechnology is a biotechnology company that provides antibodies and related products. It has 32 offices nationwide, four domestic sales subsidiaries and more than 500 employees. It set up an R&D center in Nanjing in 2018, one in Hangzhou in 2021, and a GMP-level production center in Nanjing in 2021. The company reported 2020 revenue of 849.08 million and net income of 76.48 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in